Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 545

    1.

    Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients.

    Pistrosch F, Herbrig K, Kindel B, Passauer J, Fischer S, Gross P.

    Diabetes. 2005 Jul;54(7):2206-11.PMID: 15983223 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control.

    Pistrosch F, Passauer J, Fischer S, Fuecker K, Hanefeld M, Gross P.

    Diabetes Care. 2004 Feb;27(2):484-90.PMID: 14747233 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Elevated urinary prostaglandin excretion and the effect of indomethacin on renal function in incipient diabetic nephropathy.

    Mathiesen ER, Hommel E, Olsen UB, Parving HH.

    Diabet Med. 1988 Mar;5(2):145-9.PMID: 2964980 [PubMed - indexed for MEDLINE]Related articles

    4.

    Renal functional reserve in IDDM patients.

    Sackmann H, Tran-Van T, Tack I, Hanaire-Broutin H, Tauber JP, Ader JL.

    Diabetologia. 1998 Jan;41(1):86-93.PMID: 9498635 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.

    Ahmad J, Siddiqui MA, Ahmad H.

    Diabetes Care. 1997 Oct;20(10):1576-81.PMID: 9314638 [PubMed - indexed for MEDLINE]Related articles

    6.

    Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration.

    Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, di Ricco L, Pomilio M, Pierdomenico SD, Marini M, Cuccurullo F, Mezzetti A.

    Diabetes. 2000 Jul;49(7):1258-63.PMID: 10909986 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Long-term effects of rosiglitazone on the progressive decline in renal function in patients with type 2 diabetes.

    Kim MK, Ko SH, Baek KH, Ahn YB, Yoon KH, Kang MI, Lee KW, Song KH.

    Korean J Intern Med. 2009 Sep;24(3):227-32. Epub 2009 Aug 26.PMID: 19721859 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Glomerular hyperfiltration in microalbuminuric NIDDM patients.

    Vedel P, Obel J, Nielsen FS, Bang LE, Svendsen TL, Pedersen OB, Parving HH.

    Diabetologia. 1996 Dec;39(12):1584-9.PMID: 8960846 [PubMed - indexed for MEDLINE]Related articles

    11.

    Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathy.

    Ruggenenti P, Flores C, Aros C, Ene-Iordache B, Trevisan R, Ottomano C, Remuzzi G.

    Diabetes Care. 2003 Feb;26(2):502-9.PMID: 12547889 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Atrial natriuretic peptide-induced microalbuminuria is associated with endothelial dysfunction in noncomplicated type 1 diabetes patients.

    Vervoort G, Wetzels JF, Lutterman JA, Bravenboer B, Berden JH, Smits P.

    Am J Kidney Dis. 2002 Jul;40(1):9-15.PMID: 12087555 [PubMed - indexed for MEDLINE]Related articles

    13.

    Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria.

    Dogra G, Rich L, Stanton K, Watts GF.

    Diabetologia. 2001 May;44(5):593-601.PMID: 11380077 [PubMed - indexed for MEDLINE]Related articles

    14.

    Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.

    Yu Y, Suo L, Yu H, Wang C, Tang H.

    Diabetes Res Clin Pract. 2004 Aug;65(2):95-104.PMID: 15223221 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rosiglitazone reduces urinary albumin excretion in type II diabetes.

    Bakris G, Viberti G, Weston WM, Heise M, Porter LE, Freed MI.

    J Hum Hypertens. 2003 Jan;17(1):7-12.PMID: 12571611 [PubMed - indexed for MEDLINE]Related articles

    16.

    Glomerular dysfunction in diabetic nephropathy.

    Zucchelli P, Zuccalà A, Sturani A.

    Postgrad Med J. 1988;64 Suppl 3:22-30; discussion 48-9. Review.PMID: 3074295 [PubMed - indexed for MEDLINE]Related articles

    17.

    Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes.

    Dalla Vestra M, Sacerdoti D, Bombonato G, Fioretto P, Finucci G, Saller A, Sfriso A, Bruseghin M, Sambataro M, Velussi M, Baggio B, Nosadini R, Crepaldi G.

    Eur J Endocrinol. 2002 May;146(5):687-94.PMID: 11980625 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes.

    Zerbini G, Bonfanti R, Meschi F, Bognetti E, Paesano PL, Gianolli L, Querques M, Maestroni A, Calori G, Del Maschio A, Fazio F, Luzi L, Chiumello G.

    Diabetes. 2006 Sep;55(9):2620-5.PMID: 16936212 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics.

    BENEDICT Group.

    Control Clin Trials. 2003 Aug;24(4):442-61.PMID: 12865039 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of indomethacin on kidney function in type 1 (insulin-dependent) diabetic patients with nephropathy.

    Hommel E, Mathiesen E, Arnold-Larsen S, Edsberg B, Olsen UB, Parving HH.

    Diabetologia. 1987 Feb;30(2):78-81.PMID: 3471610 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data